Salesforce Salesforce Certified Agentforce Life Sciences Consultant Als-Con-201 Exam Dumps: Updated Questions & Answers (May 2026)

The correct answer is C because Salesforce’s electronic signature capability for Life Sciences is Digital Verification . Salesforce Help states that the Electronic Signature feature provides 21 CFR Part 11-ready electronic signature functionality , and the setup guidance directs administrators to configure the Digital Verifications feature to manage electronic signatures in Salesforce rather than relying on a third-party application.

The requirement is specific to regulated sample drop-off. The system must capture the HCP’s signature image, associate it with the sample disbursement, preserve the timestamp, and maintain an audit trail that supports compliance expectations. Digital Verification is the Salesforce Life Sciences feature designed to support electronic-signature capture in this type of regulated workflow.

Option A, Shield Audit Trail , is incorrect because Salesforce Shield can help with broader platform security, event monitoring, and auditability, but it is not the Life Sciences feature that captures an HCP’s electronic signature for sample drop-off. Option B, DocuSign for Salesforce , is also incorrect because the question asks for the Agentforce Life Sciences for Customer Engagement feature that supports this requirement. Salesforce Help specifically points to Digital Verification for managing electronic signatures directly in Salesforce. Therefore, the consultant should enable Digital Verification to support the 21 CFR Part 11-ready signature and audit requirements.

=========

The correct answer is C because field sales reps only need to view and consume Tableau Next metrics in the Life Sciences mobile app. Salesforce Help for Tableau Next in Life Sciences Cloud explains that Tableau Next integrates with Life Sciences Cloud to provide actionable insights and enhanced visualizations. Salesforce’s Tableau Next permission guidance also identifies Tableau Next Consumer as the permission set used for viewing Tableau Next content and interacting with metrics, while creator-level access is intended for users who create and manage Tableau Next assets.

In this scenario, the technical setup has already been completed: the metrics exist, the Tableau View component has been placed on the Mobile Home Page Lightning record page, and the mobile metadata cache has been refreshed. The remaining issue is an insufficient-privileges error, which indicates that the user lacks the Tableau Next permissions required to load and consume the metric. Assigning Tableau Next Consumer grants the field rep the appropriate access level without giving unnecessary authoring privileges.

Option A, Tableau Next Creator , is incorrect because field sales reps are not creating or administering metrics; they only need to consume them. Option B, CRM Analytics Plus User , is also incorrect because the requirement is specifically for Tableau Next metrics, not legacy CRM Analytics access. Therefore, the consultant should assign the Tableau Next Consumer permission set.

=========

Option A, HCP Remote Platform Conference, is correct. In Salesforce Life Sciences Cloud Remote Engagement, the consultant creates an Experience Cloud site so Healthcare Providers can join remote visits. Salesforce Help specifically states that the HCP Remote Platform Conference component is available under Custom Components and can also be found through the search bar when building the Experience Cloud page. This is the component that is placed on the page to support the remote engagement conference experience.

The question also mentions video playback and Terms & Conditions logic. Salesforce Life Sciences Cloud Remote Engagement setup includes configuration for video call settings and video call Terms and Conditions, and the Experience Cloud site component is the user-facing component that brings the HCP remote conference experience onto the page. Salesforce Help also references Remote Engagement setup tasks such as configuring video call settings with Twilio and configuring video call Terms and Conditions, showing that Twilio is part of the underlying video-call configuration rather than the Experience Cloud page component itself.

Option B, Twilio Connector, is incorrect because Twilio configuration supports the video service settings, but it is not the component dragged onto the Experience Cloud page canvas. Option C, Remote Video Player, is not the standard component name identified in the Salesforce setup documentation. Therefore, the out-of-the-box component the consultant should select is HCP Remote Platform Conference.

The correct answer is C because Salesforce Life Sciences synchronization management guidance specifically positions Simulation Mode as the tool used to proactively identify and fix potential synchronization problems before they affect end users. Salesforce describes synchronization management as a way to ensure efficient synchronization by resolving errors quickly and using Simulation Mode to find potential problems before they impact users.

In this scenario, sales users are unable to view recently created records offline in the Agentforce Life Sciences mobile app because synchronization transactions have failed. Offline mobile availability depends on successful synchronization between Salesforce and the mobile app. A consultant should therefore recommend testing synchronization behavior in Simulation Mode, because it helps validate whether records, transactions, and configuration changes will synchronize successfully before users rely on them in the field.

Option A is not the best answer because Event Monitoring Logs are broader Salesforce security and activity logs; they are not the recommended Life Sciences-specific mechanism for proactively identifying synchronization transaction failures in the offline mobile synchronization process. Option B is also incorrect because warning emails notify users or administrators after certain conditions occur, but they do not test synchronization transactions or identify potential sync failures before users are affected. Simulation Mode is the most targeted and preventive administrative tool for this issue.

The correct answer is B because Salesforce Life Sciences Cloud for Customer Engagement includes country-specific sample limit templates by default. Salesforce Help states that Life Sciences Cloud includes a generic sample limit template and several country-specific templates by default. These templates are intended to support sample-limit compliance where rules vary by country, including situations where statutory limits must be consistently applied without requiring administrators to rebuild complex legal rules from scratch.

In this scenario, Germany has strict legal limits on sample quantities that must apply to all HCPs. A default country-specific template is the best fit because it is designed to represent country-level sample compliance requirements in a reusable configuration. This approach reduces administrative maintenance, improves consistency, and helps ensure the sampling program follows local legal constraints.

Option A is incorrect because adding a new sample limit to custom metadata would require the admin or implementation team to manually maintain rule logic, which the requirement explicitly wants to avoid. Option C is also not the best answer because manually creating a sample limit rule in the Admin Console may work for custom business policies, but it is less appropriate when Salesforce provides a default country-specific template for statutory country rules. Therefore, the consultant should use the Default Country-Specific Template for Germany.

=========

The correct answer is C because sample visibility during visits depends on the product being configured as a Life Sciences Marketable Product with an appropriate distribution method. Salesforce Help for setting up Sample Inventory Management data states that, to designate a product as a sample product, administrators create a corresponding Life Science Marketable Product record. Salesforce’s Life Sciences Cloud Developer Guide for LifeSciMarketableProduct identifies distribution methods such as Drop , DropAndShip , and Ship , which define how a product is distributed to a provider.

In a provider visit, a product must be configured as marketable and available for the relevant distribution method before reps can select it for sample drop-off. If the product is meant to be handed directly to the HCP during the visit, the distribution method must include Drop . If it can be either handed off during the visit or shipped, Drop and Ship is appropriate. This setup makes the product eligible for visit-based sampling workflows.

Option A is incorrect because permissions alone do not make a specific sample product visible. Reps may have access to sampling functionality, but the product still must be configured correctly. Option B is also incorrect because profile configuration in Visit Administration is not the key product-availability control. The essential configuration is the Life Sciences Marketable Product record with the correct distribution method. Therefore, the consultant should set the distribution method to Drop or Drop and Ship .

Option A is correct because the requirement is specifically to allow field sales reps to add colleagues as CC recipients when sending emails from the Life Sciences Cloud mobile app. Salesforce Help for customizing and sending emails in Life Sciences Cloud states that users can send emails from the Life Sciences Cloud mobile app from areas such as the home page, visit and account records, the content library, and the presentation player. The same Salesforce Help result also states that users can add colleagues as CC recipients, depending on the Salesforce admin’s configuration.

That wording directly matches the option “Add Colleagues as CC.” The purpose of the setting is not simply to expose a generic CC field, but to enable the Life Sciences mobile email experience where reps can copy internal colleagues on compliant business communications.

Option B, “Add CC Recipients,” is too generic and does not match the Life Sciences-specific setting name in the question. It describes the general email behavior but not the precise admin setting. Option C, “Enable CC Field Representative,” is also not correct because it implies a setting focused on copying the field representative, rather than allowing the field representative to add colleagues as CC recipients.

Therefore, to let field sales reps CC colleagues from the Agentforce Life Sciences mobile app, the consultant should enable Add Colleagues as CC.

=========

Option C is correct because the business requirement is based on the HCP’s relationship with a hospital, not the HCP’s primary address. Salesforce Life Sciences Cloud Affiliations help organizations understand and map relationships between Healthcare Providers and Healthcare Organizations. Salesforce Help also describes Territory Alignment for Affiliated Accounts, where affiliated accounts can be aligned to territories based on affiliation relationships. This fits the scenario: the HCP’s primary address points to San Francisco South, but their practice relationship with a hospital points to San Francisco North.

Option A is not the best answer because manually assigning the HCP to San Francisco North and excluding the record from future assignment rules creates a one-off exception. That may work temporarily, but it does not meet the requirement for automatic mapping based on practice location and affiliation. Option B is incorrect because it would use the HCP’s primary address zip code, which the scenario says is aligned to San Francisco South. That would produce the wrong territory.

An affiliation assignment rule aligns the HCP based on their relationship with the hospital, so the HCP can be mapped to San Francisco North when the hospital affiliation drives the business alignment. Therefore, the correct configuration is to set up an affiliation assignment rule based on the HCP-HCO relationship.

=========

Option C is correct because the requirement is product-specific and should be configured through Product Discussion Settings, not through a generic page-layout or Visit validation rule. Salesforce’s Life Sciences Cloud Visit Management data model includes Provider Visit Product Discussion as the object that represents products discussed during a visit, including key details about the product brand, therapeutic area, and related information. Salesforce also documents ProviderVisitProdDiscussion as representing additional notes or information about products discussed during a healthcare provider visit.

The question asks for a configuration that applies when a specific product, such as Immunexis, is discussed. Enabling Require Discussion in Product Discussion Settings for the product record is the most targeted standard configuration because it ties the requirement to that product’s visit discussion behavior.

Option A is not the best answer because a custom validation rule on Visit would have to inspect related product-discussion records and could become complex or unreliable for mobile visit submission behavior. Option B is also insufficient because making a Comments field required on the page layout would apply based on the layout, not specifically when Immunexis is discussed. It also would not necessarily enforce product-specific discussion requirements across all relevant visit submission paths. Therefore, the consultant should enable Require Discussion in Product Discussion Settings for the Immunexis product record.

=========

The correct answer is A because Today’s Pace is tied to the Activity Plan’s calculation behavior, not the home page component itself. Salesforce describes Activity Plans as a way to establish a strategic activity plan and define activity goals for sales representatives over a specific period. Salesforce’s Life Sciences Activity Plans developer guidance also describes Activity Plans as allowing administrators to define goals for specific employees, including targeted accounts, plan-cycle duration, activity types, and progress tracking.

When the business wants Today’s Pace calculated based on working days, that logic should be defined where the activity plan is created and governed. Selecting Working Days in the Today’s Pace Calculation Type field ensures the pacing metric uses working-day logic for the plan instead of simply counting all calendar days. This is the correct place to configure the calculation because Today’s Pace reflects plan progress against the plan timeline.

Option B is incorrect because editing the home page component only controls presentation. A component can display the metric, but it should not be the source of the calculation rules for the underlying Activity Plan. Option C is also not the best answer because the requirement is not a broad global enablement setting; it asks how to calculate Today’s Pace for the relevant Activity Plan. Therefore, the consultant should configure the calculation type directly on the Activity Plan by selecting Working Days .